Assignee
REPRISE PHARMACEUTICALS INC
US·1 granted patent·5 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
6 records- 0159US2023404949A1Method of treating or preventing neurodegenerationREPRISE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0256US2022105059A1Method of treating or preventing neurodegenerationREPRISE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0353US11376229B2Method of treating or preventing neurodegenerationREPRISE PHARMACEUTICALS INC·Filed 2020·Granted Jul 5, 2022·0 cites·6 claims
- 0451US2021052526A1Method of treating or preventing neurodegenerationREPRISE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0548US2023201225A1Methods of treating multiple sclerosisREPRISE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0639US2023099229A1Methods of treating multiple sclerosisREPRISE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →